Mixed Trial Results Tempered by mRNA Success Challenge Cancer Vaccine Timeline

By Amanda Erickson · STAT News · 2026-10-05

STAT News reports that the development of universal cancer vaccines remains in a state of flux following contradictory clinical data. While a combination of mRNA technology and immunotherapy recently showed promise in reducing melanoma recurrence, a separate German pharmaceutical

STAT News reports that the development of universal cancer vaccines remains in a state of flux following contradictory clinical data. While a combination of mRNA technology and immunotherapy recently showed promise in reducing melanoma recurrence, a separate German pharmaceutical